...
首页> 外文期刊>Human gene therapy methods. >Optimizing Delivery and Expression of Designer Nucleases for Genome Engineering
【24h】

Optimizing Delivery and Expression of Designer Nucleases for Genome Engineering

机译:为基因组工程优化设计者核酸酶的递送和表达

获取原文
获取原文并翻译 | 示例
           

摘要

Genome engineering can be accomplished by designer nucleases. They are specifically designed to cleave double-stranded DNA at the desired target locus. This double-strand break subsequently engages the DNA repair pathway through nonhomologous end-joining (NHEJ), resulting in either gene disruption or gene repair. Alternatively, the presence of homologous donor DNA allows for targeted integration of this exogenous donor DNA in this target locus through homology-directed DNA repair. The key bottleneck in genome engineering relates to the delivery and expression of the designer nucleases. One of the most attractive vector platforms for genome engineering is based on integration-defective lentiviral vectors (IDLVs). The intrinsic episomal nature of IDLVs is well suited to ensure transient expression of designer nucleases and minimize potential risks associated with their sustained expression. Unfortunately, their expression is compromised because of epigenetic silencing that interferes with the transcriptional competence of IDLVs. In this issue, Pelascini and colleagues now showed that this bottleneck could be overcome by interfering with chromatin remodeling using histone deacetylase (HDAC) inhibitors. HDAC inhibition restored expression of designer nucleases from IDLVs and rescued their ability to achieve efficient targeted gene disruption by NHEJ comparable with that achieved with bona fide integrating lentiviral vectors. This study has implications for the ex vivo use of IDLVs for gene repair and gene targeting.
机译:基因组工程可以通过设计者核酸酶来完成。它们经过专门设计,可在所需靶位点切割双链DNA。该双链断裂随后通过非同源末端连接(NHEJ)参与DNA修复途径,导致基因破坏或基因修复。或者,同源供体DNA的存在允许通过同源性指导的DNA修复将这种外源供体DNA靶向整合到该靶基因座中。基因组工程中的关键瓶颈与设计者核酸酶的传递和表达有关。基因组工程最有吸引力的载体平台之一是基于整合缺陷型慢病毒载体(IDLV)。 IDLV的固有附加性质非常适合确保设计者核酸酶的瞬时表达,并将与它们持续表达相关的潜在风险降至最低。不幸的是,由于表观遗传沉默会干扰IDLV的转录能力,因此它们的表达受到损害。在此问题中,Pelascini及其同事现在表明,可以通过使用组蛋白脱乙酰基酶(HDAC)抑制剂干扰染色质重塑来克服这一瓶颈。 HDAC抑制恢复了IDLV中设计者核酸酶的表达,并挽救了它们通过NHEJ实现与有效整合慢病毒载体相当的有效靶向基因破坏的能力。这项研究对IDLV在基因修复和基因靶向中的离体使用具有影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号